98627-70-4Relevant articles and documents
THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME
-
Paragraph 0570-0571, (2018/11/24)
The present disclosure relates to materials and methods of conjugating a water soluble polymer to a therapeutic protein.
BLOOD COAGULATION PROTEIN CONJUGATES
-
Paragraph 0137, (2016/12/26)
The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a blood coagulation protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer. In one embodiment of the invention the conjugation is carried out in the presence of the nucleophilic catalyst aniline. In addition the generated oxime linkage can be stabilized by reduction with NaCNBH3 to form an alkoxyamine linkage.
COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
-
Paragraph 0746, (2016/07/27)
Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one oximine, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
A model study for tethering of (bio)active molecules to biomaterial surfaces through arginine
Taraballi,Russo,Battocchio,Polzonetti,Nicotra,Cipolla
supporting information, p. 4089 - 4092 (2014/06/10)
A new approach for tethering of bioactive molecules via arginine is proposed and validated on collagen 2D matrices. The method involves the introduction of a methyl ketone on arginine side-chains, followed by reaction with model alkoxyamino derivatives. This journal is the Partner Organisations 2014.
PHENAZINE AND QUINOXALINE SUBSTITUTED AMINO ACIDS AND POLYPEPTIDES
-
Page/Page column 41, (2008/12/07)
Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a phenazine or quinoxaline substituent. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides.
PRODUCTION OF α,ω-DI(N-ALKOXY-N',N'-DIMETHYLCARBAMOYLAMINOOXY)OLIGOOXAALKANES BY ALCOHOLYSIS OF α,ω-DI(N-CHLORO-N',N'-DIMETHYLCARBAMOYLAMINOOXY)OLIGOOXAALKANES
Shtamburg, V. G.,Dmitrenko, A. A.,Pleshkova, A. P.,Pritykin, L. M.
, p. 1464 - 1470 (2007/10/02)
During the alcoholysis of α,ω-di(N-chloro-N',N'-dimethylcarbamoylaminooxy)oligooxaalkanes in the presence of sodium acetate or 2,4,6-trimethylpyridine the products from nucleophilic substitution of the chlorine atom by the alkoxy group are formed selectively.
